• Baseline HIV-1 resistance, virological outcomes, and emergent resistance in the SECOND-LINE trial: an exploratory analysis.
  Boyd MA et al, Lancet HIV 2015; 2: e42–51
  Posted on April 19th, 2015 - Dr Anton Pozniak

---

Back to Home page